AHA GUIDELINES Bundle (free trial)

Lower Extremity Peripheral Artery Disease 2024

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1521560

Contents of this Issue


Page 55 of 55

Disclaimer is resource is for informational purposes only, intended as a quick-reference tool based on the cited source guideline(s), and should not be used as a substitute for the independent professional judgment of healthcare providers. Practice guidelines are unable to account for every individual variation among patients or take the place of clinician judgment, and the ultimate decision concerning the propriety of any course of conduct must be made by healthcare providers aer consideration of each individual patient situation. Guideline Central does not endorse any specific guideline(s) or guideline recommendations and has not independently verified the accuracy hereof. Any use of this resource or any other Guideline Central resources is strictly voluntary. Source Gornik HL, Aronow HD, Goodney PP, Arya S, Brewster LP, Byrd L, Chandra V, Drachman DE, Eaves JM, Ehrman JK, Evans JN, Getchius TS, Gutiérrez JA, Hawkins BM, Hess CN, Ho KJ, Jones WS, Kim ES, Kinlay S, Kirksey L, Kohlman-Trigoboff D, Long CA, Pollak AW, Sabri SS, Sadwin LB, Secemsky EA, Serhal M, Shishehbor MH, Treat-Jacobson D, Wilkins LR. 2024 ACC/AHA/AACVPR/APMA/ ABC/SCAI/SVM/SVN/SVS/SIR/VESS guideline for the management of lower extremity peripheral artery disease: a report of the American College of Cardiolog y/American Heart Association Joint Committee on Clinical Practice Guidelines. [published online ahead of print May 14, 2024]. J Am Coll Cardiol. doi: 10.1016/j.jacc.2024.02.013. Copublished in Circulation. doi: 10.1161/CIR.0000000000001251. ACCPAD04243 TEL: 407.878.7606 • FAX: 407.878.7611 Order additional copies at GuidelineCentral.com Copyright © 2024 All rights reserved GuidelineCentral.com Abbreviations 6MWT, 6-minute walk test; AAA, abdominal aortic aneurysm; ABI, ankle-brachial index; ACE, angiotensin-converting enzyme; AFIB, atrial fibrillation; ALI, acute limb ischemia; APP, Advanced Practice Provider; ARB, angiotensin-receptor blocker; CAD, coronary artery disease; CKD, chronic kidney disease; CLTI, chronic limb-threatening ischemia; COMPASS, Cardiovascular Outcomes for People Using Anticoagulation Strategies; COVID-19, coronavirus disease 2019; CTA, computed tomography angiography; CVD, cardiovascular disease; ESKD, end-stage kidney disease; EUCLID, Examining Use of Ticagrelor in Peripheral Artery Disease; FDA, US Food and Drug Administration; GDMT, guideline-directed management and therapy; GLASS, Global Limb Anatomic Staging System; GNRI, Geriatric Nutritional Risk Index; HR, hazard ratio; ICD, International Classification of Diseases; LDL-C, low-density lipoprotein-cholesterol; MACE, major adverse cardiovascular events; MALE, major adverse limb events; MI, myocardial infarction; MRA, magnetic resonance angiography; NPWT, negative pressure wound therapy; OR, odds ratio; PAD, peripheral artery disease; PTA, percutaneous transluminal angioplasty; PVR, pulse volume recording ; QOL, quality of life; RCT, randomized controlled trial; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; SBP, systolic blood pressure; SET, supervised exercise therapy; SGLT-2, sodium-glucose cotransporter-2; SPP, skin perfusion pressure; TBI, toe-brachial index; TcPO 2 , transcutaneous oxygen pressure; VA, US Department of Veterans Affairs; VOYAGER PAD, Vascular Outcomes Study of ASA (acetylsalicylic acid) Along with Rivaroxaban in Endovascular or Surgical Limb Revascularization for PAD; WIf I, wound, ischemia, and foot infection

Articles in this issue

Links on this page

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Lower Extremity Peripheral Artery Disease 2024